IDWeek 2015: HIV

IDWeek 2015: HIV

Tenofovir Prodrug Effective in HIV-1 Infected Virologically Suppressed Adults

HIV-1 infected virologically suppressed adults who were randomized to switch from elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF) to a once-daily E/C/F/tenofovir alafenamide regimen maintained high virologic control at Week 48 compared with those who remained on E/C/F/TDF, study results presented at IDWeek 2015 have found.